Venus MedTech (Hangzhou) Inc.
Clinical trials sponsored by Venus MedTech (Hangzhou) Inc., explained in plain language.
Venus MedTech (Hangzhou) Inc.
2500
HKEX
A medical device company focused on structural heart disease treatments.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.